Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA.
Divisions of Reproductive Genetics and Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Am J Obstet Gynecol. 2023 Feb;228(2):178-186. doi: 10.1016/j.ajog.2022.08.039. Epub 2022 Aug 24.
Establishing the diagnosis of a fetal genetic disease in utero expands decision-making opportunities for individuals during pregnancy and enables providers to tailor prenatal care and surveillance to disease-specific risks. The selection of prenatal genetic tests is guided by key details from fetal imaging, family and obstetrical history, suspected diagnoses and mechanisms of disease, an accurate understanding of what abnormalities each test is designed to detect, and, at times, the gestational age at which testing is initiated. Pre- and posttest counseling, by or in conjunction with providers trained in genetics, ensure an accurate understanding of genetic tests, their potential results and limitations, estimated turnaround time for results, and the clinical implications of their findings. As prenatal diagnosis and testing options continue to expand rapidly, it is increasingly important for obstetrical providers to understand how to choose appropriate genetic testing and contextualize the clinical implications of their results.
在子宫内确定胎儿的遗传疾病诊断,为个人在怀孕期间提供了更多的决策机会,并使提供者能够根据疾病的特定风险来定制产前护理和监测。产前遗传检测的选择由胎儿影像学、家族和产科病史、疑似诊断和疾病机制的关键细节指导,准确了解每个检测旨在检测到的异常情况,有时还包括开始检测的孕龄。由或与经过遗传学培训的提供者进行的产前和产后咨询,可确保对遗传检测、其潜在结果和局限性、结果的估计周转时间以及其发现的临床意义有准确的理解。随着产前诊断和检测选择的迅速扩展,产科提供者越来越需要了解如何选择适当的遗传检测,并使他们的结果的临床意义得到体现。